Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine Versus Divalproex and Placebo in Mild to Moderate Mania in Bipolar I Disorder
2004-001482-17Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of olanzapine in bipolar I disorder (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: Young Mania Rating Scale total score change. Started Oct 2004; status: completed.
02
Drugs
olanzapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2004-001482-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001482-17.